These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7925293)

  • 1. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.
    Andoniou CE; Thien CB; Langdon WY
    EMBO J; 1994 Oct; 13(19):4515-23. PubMed ID: 7925293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V; Hubbell S; Herrera R; Saltiel AR
    Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
    Andoniou CE; Thien CB; Langdon WY
    Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
    Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation.
    Blake TJ; Heath KG; Langdon WY
    EMBO J; 1993 May; 12(5):2017-26. PubMed ID: 8491192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.
    Blake TJ; Shapiro M; Morse HC; Langdon WY
    Oncogene; 1991 Apr; 6(4):653-7. PubMed ID: 2030914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-CBL is not required for leukemia induction by Bcr-Abl in mice.
    Dinulescu DM; Wood LJ; Shen L; Loriaux M; Corless CL; Gross AW; Ren R; Deininger MW; Druker BJ
    Oncogene; 2003 Dec; 22(55):8852-60. PubMed ID: 14654781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
    J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.
    Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ
    Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The localization of the products of the c-cbl and v-cbl oncogenes during mitosis and transformation.
    Langdon WY; Heath KG; Blake TJ
    Curr Top Microbiol Immunol; 1992; 182():467-74. PubMed ID: 1490387
    [No Abstract]   [Full Text] [Related]  

  • 17. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase.
    Panchamoorthy G; Fukazawa T; Miyake S; Soltoff S; Reedquist K; Druker B; Shoelson S; Cantley L; Band H
    J Biol Chem; 1996 Feb; 271(6):3187-94. PubMed ID: 8621719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cbl family of signal transduction molecules.
    Smit L; Borst J
    Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cbl oncogene: a novel substrate of protein tyrosine kinases.
    Langdon WY
    Aust N Z J Med; 1995 Dec; 25(6):859-64. PubMed ID: 8770364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of fcgamma receptor-mediated phagocytosis by transforming mutants of Cbl.
    Sato N; Kim MK; Schreiber AD
    J Immunol; 1999 Dec; 163(11):6123-31. PubMed ID: 10570302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.